NCT07318831 2026-01-06Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in ChildrenTianjin Medical University Cancer Institute and HospitalPhase 2 Not yet recruiting27 enrolled